In a significant development for European stroke care, Brainomix, the leading stroke AI imaging software provider, has established a strategic partnership with medical technology giant Medtronic Neurovascular. The collaboration, announced on February 27, 2025, aims to revolutionize stroke treatment across Western Europe by implementing advanced artificial intelligence solutions in clinical settings.
Proven Impact of AI Technology
The partnership centers on the Brainomix 360 Stroke platform, an AI-powered system that provides immediate interpretation of brain scans to support critical treatment decisions. The platform's effectiveness has been validated through extensive real-world evaluation, analyzing data from over 450,000 patients across England over five years. Healthcare facilities utilizing the Brainomix system demonstrated remarkable improvements, including doubled thrombectomy rates and a 37% increase in treatment delivery compared to non-participating sites.
Advancing Clinical Decision-Making
The integration of Brainomix's imaging technology with Medtronic's established neurovascular expertise represents a significant advancement in stroke care delivery. This collaboration enables healthcare professionals to make more informed decisions with greater speed and precision, potentially saving crucial time in emergency situations.
Dr. Michalis Papadakis, CEO and Co-Founder of Brainomix, emphasized the strategic importance of the partnership: "This partnership with Medtronic is a natural fit, with the leading neurovascular device provider joining forces with the leading stroke AI imaging partner, both aligned around a mutual commitment towards improving stroke care for all patients."
Clinical Perspective and Future Impact
Dr. Alex Solich, Senior Consultant for Neurointervention at Karolinska University Hospital & Örebro Hospital, offered insights into the clinical significance of this collaboration: "As a stroke physician, I see firsthand the critical importance of speed and precision in delivering life-saving treatment. Combining Medtronic's proven neurovascular technologies with Brainomix's AI-driven imaging has the potential to make a real difference—not just in streamlining workflows, but in giving patients a better chance at recovery."
The partnership is expected to enhance stroke care networks throughout Europe, potentially improving access to critical treatments and setting new standards for stroke care delivery. By leveraging AI technology and clinical expertise, this collaboration aims to optimize treatment pathways and ultimately enhance patient outcomes across the region.
